Publikationen, an denen er mitarbeitet ANA AURORA DIAZ GAVELA (11)

2024

  1. Apparent Diffusion Coefficient as an Early Prognostic Factor of Response to Treatment with Androgen Deprivation Therapy and Radiotherapy in Patients with Prostate Cancer (Póster)

    International Journal of Radiation Oncology*Biology*Physics, Vol. 120, Núm. 2, pp. e527

  2. Hypofractionated whole breast IMRT with HDR brachytherapy boost in early-stage breast cancer: Long-term results from a single-center

    Brachytherapy, Vol. 23, Núm. 3, pp. 342-354

  3. Real-Life Impact of Hypofractionated IMRT in Early Breast Cancer on Cardiovascular Risk

    International Journal of Radiation Oncology*Biology*Physics

2023

  1. Jorge clinical study: 10-year outcomes of risk-adapted radiotherapy defined by multiparametric MRI for prostate cancer

    World Journal of Urology, Vol. 41, Núm. 12, pp. 3829-3838

2021

  1. Breast cancer radiotherapy: What physicians need to know in the era of the precision medicine

    Breast Disease, Vol. 40, Núm. 1, pp. 1-16

2020

  1. Impact of 68Ga-PSMA PET/CT in the treatment of prostate cancer: Initial experience in Spain

    Reports of Practical Oncology and Radiotherapy, Vol. 25, Núm. 3, pp. 405-411

2019

  1. Multiparametric magnetic resonance imaging-guided salvage radiotherapy in prostate cancer

    Reports of Practical Oncology and Radiotherapy, Vol. 24, Núm. 5, pp. 472-480

2016

  1. Endorectal magnetic resonance imaging for risk classification of localized prostate cancer: Radiographic findings and influence on treatment decisions

    Urologic Oncology: Seminars and Original Investigations

  2. Evaluation of tumor recurrences after radical prostatectomy using 18F-Choline PET/CT and 3T multiparametric MRI without endorectal coil: A single center experience

    Cancer Imaging, Vol. 16, Núm. 1

  3. Letter by Couñago et al. regarding article “Impact of multiparametric magnetic resonance imaging on risk group assessment of patients with prostate cancer addressed to external beam radiation therapy”

    European Journal of Radiology

2015

  1. Tumor staging using 3.0 T multiparametric MRI in prostate cancer: impact on treatment decisions for radical radiotherapy

    SpringerPlus, Vol. 4, Núm. 1, pp. 1-8